Sightdx
3 known investors
Find your way into Sightdx
Sign up to see every warm intro you have to Sightdx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sightdx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sight develops immune signatures by analyzing live immune cells using AI to generate clinical insights. The company applies proprietary data and machine learning to immune cell analysis for diagnostic and clinical applications.
Founders & leadership
BL
Ben LeshemChief Technology Officer
NM
Nitsan Maayan-RabinowichChief Executive Officer
AC
Asi Cohen-DotanChief Product & Clinical Officer
Investors · 3
Frequently asked questions
- What does Sightdx do?
- Sight develops immune signatures by analyzing live immune cells using AI to generate clinical insights. The company applies proprietary data and machine learning to immune cell analysis for diagnostic and clinical applications.
- Who are Sightdx's investors?
- Sightdx's investors include Clal Biotechnology Industries, Emery Capital, GEOC.
